Press Releases Archives - Page 2 of 3

Marketing authorization received for Lyfaquin™ (centhaquine) to treat patients with hypovolemic shock from Indian regulatory agency

by michael | May 14, 2020 | Pharmazz, Press Releases

WILLOWBROOK, Ill., May 14, 2020 /PRNewswire/ — Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, today announced that it has received marketing authorization of...

Sovateltide significantly (p=0.0157) improved clinical outcome (modified Rankin Scale) in patients with acute cerebral ischemic stroke when compared to standard of care

by michael | Apr 27, 2020 | Pharmazz, Press Releases

WILLOWBROOK, Ill., April 27, 2020 /PRNewswire/ — Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, today announced that sovateltide, an endothelin-B receptor...

Cyber Security Webinar – 22 April 2020 at 1:30 PM (GMT+3): Beat ZERO-DAY MALWARE with the finest prevention product available

by michael | Apr 20, 2020 | Almana Computer Services, Blue Ridge Networks, Press Releases

Join us for a revealing cyber security webinar that will show you how to beat ZERO-DAY MALWARE with the finest prevention product available! SAVE THE DATE: 22nd April 2020 at 1:30 PM Doha time (GMT +3). RSVP: send email to info@clearspanstrategic.com stating your...

Willkie Expands Chicago Office With Addition of Michael G. Babbitt

by michael | Apr 15, 2020 | Press Releases

New York, NY (April 15, 2020) — Willkie Farr & Gallagher LLP today announced that Michael G. Babbitt has joined the Firm as a partner in the Chicago office as part of the Intellectual Property practice. His arrival follows the Firm’s announcement on March 31...

Centhaquine can provide hemodynamic stability, improve tissue oxygenation, reduce pulmonary edema, acute respiratory distress syndrome (ARDS), multiple organ dysfunction score (MODS) and mortality in coronavirus disease 2019 (COVID-19) patients

by michael | Apr 9, 2020 | Pharmazz, Press Releases

WILLOWBROOK, Ill., April 9, 2020 /PRNewswire/ — Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, today announced that centhaquine, a drug in final stage of...

Blue Ridge Networks Provides Industry-Leading Cybersecurity in Qatar

by michael | Apr 2, 2020 | Blue Ridge Networks, Press Releases

CHANTILLY, Va., April 2, 2020 /PRNewswire/ — Blue Ridge Networks today announced that it will provide proven endpoint and critical infrastructure cyber security solutions for Qatar’s private and public sectors through its partners Clearspan Strategic LLC...